Overview
Announcements

Methodology Change | BBVA Health & Wellness | Effective Date 11/04/2023

Today, on the 24/03/2023, Solactive announces the following changes to the methodology of the following Indices (the ‘Affected Indices’):

Solactive BBVA Health & Wellness EUR Index NTR .SBVHAWEN DE000SL0DND5
Solactive BBVA Health & Wellness EUR Index PR .SBVHAWEP DE000SL0DK31
Solactive BBVA Health & Wellness EUR Index TR .SBVHAWET DE000SL0DNE3
Solactive BBVA Health & Wellness SIC MXN Index NTR .SBVHAWPN DE000SL0EE61
Solactive BBVA Health & Wellness SIC MXN Index PR .SBVHAWPP DE000SL0EE53
Solactive BBVA Health & Wellness SIC MXN Index TR .SBVHAWPT DE000SL0EE79
Solactive BQIS Health & Wellness PLN Index NTR .SBVHAWLN DE000SL0GM77
Solactive BQIS Health & Wellness PLN Index PR .SBVHAWLP DE000SL0GM69
Solactive BQIS Health & Wellness PLN Index TR .SBVHAWLT DE000SL0GM85

 

Rationale for  Methodology Change

The Affected Indices aim to represent the companies that are actively engaged in Solactive BBVA Health & Wellness EUR Indices. Solactive has determined that the Solactive BBVA Health & Wellness EUR Index has grown over time and additional companies have entered this rising business segment. Therefore, to ensure a more accurate reflection of the index objective, it is proposed to update the list of FactSet RBICs sectors eligible for the index selection.

Changes to the Index Guideline

The following Methodology changes are proposed in the following points of the Index Guideline (ordered in accordance with the numbering of the affected sections):

 

Section 7.1 Sectors

 

FactSet RBICs sectors removed:

Code Name BBVA Sector Bucket
351010101015 Broad Spectrum Antibacterial Agents Infectious Diseases and Pandemics Prevention

 

FactSet RBICs sectors added:

Code Name BBVA Sector Bucket
352010101035 Diabetes Diagnostic Testing Devices   Chronic Diseases Treatment
352010151515 Diabetes Drug Delivery Devices Chronic Diseases Treatment
352010101030 Diabetes Home Monitoring Devices Chronic Diseases Treatment
352010151015 Diabetes Infusion Drug Delivery Devices Chronic Diseases Treatment
351515251015 Telemedicine Healthcare Management

 

Defined terms used in this announcement, but not defined herein, have the meaning assigned to them in the respective index guideline of the Affected Indices. The amended version of the index guideline will be available on the effective date.